Spotlight on Impactful Research: Low-Dose Valganciclovir for Cytomegalovirus Prophylaxis in Intermediate-Risk Liver Transplantation Recipients
- PMID: 33680435
- PMCID: PMC7916437
- DOI: 10.1002/cld.962
Spotlight on Impactful Research: Low-Dose Valganciclovir for Cytomegalovirus Prophylaxis in Intermediate-Risk Liver Transplantation Recipients
References
-
- Fishman JA. Infection in organ transplantation. Am J Transplant 2017;17:856‐879. - PubMed
-
- Kotton CN, Kumar D, Caliendo AM, et al; Transplantation Society International CMV Consensus Group . Updated international consensus guidelines on the management of cytomegalovirus in solid‐organ transplantation. Transplantation 2013;96:333‐360. - PubMed
-
- Gardiner BJ, Chow JK, Brilleman SL, et al. The impact of recurrent cytomegalovirus infection on long‐term survival in solid organ transplant recipients. Transpl Infect Dis 2019;21:e13189. - PubMed
-
- Stratta RJ, Shaefer MS, Markin RS, et al. Clinical patterns of cytomegalovirus disease after liver transplantation. Arch Surg 1989;124:1443‐1449; discussion 1449‐1450. - PubMed
-
- Young PG, Rubin J, Angarone M, et al. Ganciclovir‐resistant cytomegalovirus infection in solid organ transplant recipients: a single‐center retrospective cohort study. Transpl Infect Dis 2016;18:390‐395. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
